<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000651169"><TermName>5-alpha reductase inhibitor</TermName><TermPronunciation>(5-AL-fuh ree-DUK-tays in-HIH-bih-ter)</TermPronunciation><TermDefinition><DefinitionText>A substance that blocks an enzyme needed by the body to make dihydrotestosterone (a male sex hormone made from testosterone).  Dihydrotestosterone can cause the prostate to grow.  5-alpha reductase inhibitors are used to shrink an enlarged prostate gland and to improve the flow of urine in a condition called benign prostatic hyperplasia (BPH).  A 5-alpha reductase inhibitor is a type of enzyme inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726482" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;5-alpha reductase inhibitor&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726481" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de 5-alfa reductasa&quot;" language="es" id="_4"/><SpanishTermName>inhibidor de 5-alfa reductasa</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia que bloquea una enzima que el cuerpo necesita para elaborar dihidrotestosterona (una hormona sexual masculina compuesta de testosterona). La dihidrotestosterona puede hacer crecer la próstata. Los inhibidores de la 5-alfa reductasa se usan para disminuir el tamaño de una próstata agrandada y mejorar el flujo de la orina cuando hay una afección que se llama hiperplasia prostática benigna (HPB). Un inhibidor de la 5-alfa reductasa es un tipo de inhibidor enzimático.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-08-26</DateFirstPublished></GlossaryTerm>
